secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2026-03-27T23:59:59+00:00
Accession:  0001193125-26-129431
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q32 Bio enters ATM sales agreement for up to $14.2M common stock offering
-------------------------------------------------------------------------

- Enters Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. for at-the-market sales.
- May sell shares with aggregate offering price up to $14.2 million via prospectus supplement filed March 27, 2026.
- Sales made on Nasdaq or other trading markets; Agent receives 3.0% cash commission on gross proceeds.
- Company not obligated to sell any shares; can suspend or terminate offering on notice to Agent.
- Uses existing shelf registration statement Form S-3 (File No. 333-286491) effective April 21, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526129431/0001193125-26-129431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526129431/d12934d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-129431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer